Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Recall DMAA Analog While FDA Evaluates Safety – CRN, Researchers

This article was originally published in The Tan Sheet

Executive Summary

An analog of the prohibited ingredient DMAA is found in products marketed as dietary supplements and poses a safety threat to consumers, according to research. The researchers say finding the ingredient in products available in the U.S. underscores the limits of FDA’s supplement regulations.


Related Content

SARMs Spells Latest 'Synthetic Steroids' FDA Finds In Supplements
DMAA Direct Seller Shut Down: Health And Wellness Industry News Roundup
FDA Ushers Out Known DMAA, Closes Dietary Ingredient Door





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts